Skip to content

LYVA Labs awarded contract to support university spin-out commercialisation programme

 

Pipette

LYVA Labs has won a contract to help deliver a new programme led by the Liverpool School of Tropical Medicine, to support the Higher Education Institute sector to progress innovation ideas from early-stage R&D to commercially viable products - boosting the UK economy.

The funding is from Research England’s Connecting Capability Fund, and the programme: Sustainable Innovation in Global Health Technology (SIGHT) will support the creation of a technology transfer office and a venture-building model, to drive innovation in global health technologies.

The project is a collaboration between the Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine,    University of London, and Brighton and Sussex Medical School, along with partners, LYVA Labs, Oxentia, and iiCON.

LYVA Labs will develop a modular training approach for academics and researchers to complement funding programmes, whilst accelerating innovation and entrepreneurship. Translational research projects will take part in an incubation programme, to test commercial viability, and researchers will be given the chance to explore IP and to develop their business development and proposition, and marketing acumen.